Literature DB >> 27864967

Chemokine receptors in allergic diseases.

L Castan1,2,3,4, A Magnan2,3,5, G Bouchaud1.   

Abstract

Under homeostatic conditions, as well as in various diseases, leukocyte migration is a crucial issue for the immune system that is mainly organized through the activation of bone marrow-derived cells in various tissues. Immune cell trafficking is orchestrated by a family of small proteins called chemokines. Leukocytes express cell-surface receptors that bind to chemokines and trigger transendothelial migration. Most allergic diseases, such as asthma, rhinitis, food allergies, and atopic dermatitis, are generally classified by the tissue rather than the type of inflammation, making the chemokine/chemokine receptor system a key point of the immune response. Moreover, because small antagonists can easily block such receptors, various molecules have been developed to suppress the recruitment of immune cells during allergic reactions, representing potential new drugs for allergies. We review the chemokines and chemokine receptors that are important in asthma, food allergies, and atopic dermatitis and their respectively developed antagonists.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  asthma; atopic dermatitis; chemokine; chemokine receptor; food allergy

Mesh:

Substances:

Year:  2016        PMID: 27864967     DOI: 10.1111/all.13089

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  16 in total

Review 1.  G Protein-Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action.

Authors:  Stacy Gelhaus Wendell; Hao Fan; Cheng Zhang
Journal:  Pharmacol Rev       Date:  2020-01       Impact factor: 25.468

Review 2.  Chemokines in homeostasis and diseases.

Authors:  Keqiang Chen; Zhiyao Bao; Peng Tang; Wanghua Gong; Teizo Yoshimura; Ji Ming Wang
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

3.  Anti-Inflammatory Effects of Cicadidae Periostracum Extract and Oleic Acid through Inhibiting Inflammatory Chemokines Using PCR Arrays in LPS-Induced Lung inflammation In Vitro.

Authors:  Jung-Hee Hong; Young-Cheol Lee
Journal:  Life (Basel)       Date:  2022-06-08

4.  β-Arrestin-2-Dependent Signaling Promotes CCR4-mediated Chemotaxis of Murine T-Helper Type 2 Cells.

Authors:  Rui Lin; Yeon Ho Choi; David A Zidar; Julia K L Walker
Journal:  Am J Respir Cell Mol Biol       Date:  2018-06       Impact factor: 7.748

Review 5.  Role of Microbial Modulation in Management of Atopic Dermatitis in Children.

Authors:  Lies Hulshof; Belinda Van't Land; Aline B Sprikkelman; Johan Garssen
Journal:  Nutrients       Date:  2017-08-09       Impact factor: 5.717

Review 6.  Emerging Roles of G Protein-Coupled Receptors in Hepatocellular Carcinoma.

Authors:  Wen-Ting Peng; Wu-Yi Sun; Xin-Ran Li; Jia-Chang Sun; Jia-Jia Du; Wei Wei
Journal:  Int J Mol Sci       Date:  2018-05-04       Impact factor: 5.923

7.  Exploring Immune Development in Infants With Moderate to Severe Atopic Dermatitis.

Authors:  Lies Hulshof; Saskia A Overbeek; Anne L Wyllie; Mei Ling J N Chu; Debby Bogaert; Wilco de Jager; Leon M J Knippels; Elisabeth A M Sanders; Wim M C van Aalderen; Johan Garssen; Belinda Van't Land; Aline B Sprikkelman
Journal:  Front Immunol       Date:  2018-03-29       Impact factor: 7.561

8.  Association of RANTES gene polymorphisms with susceptibility to childhood asthma: A meta-analysis.

Authors:  Yan-Qin Zhang; Xiu-Xiang Gao
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

Review 9.  A guide to chemokines and their receptors.

Authors:  Catherine E Hughes; Robert J B Nibbs
Journal:  FEBS J       Date:  2018-04-24       Impact factor: 5.542

10.  Cannabinoid Receptor 2 Modulates Maturation of Dendritic Cells and Their Capacity to Induce Hapten-Induced Contact Hypersensitivity.

Authors:  Evelyn Gaffal; Andrea M Kemter; Stefanie Scheu; Rafael Leite Dantas; Jens Vogt; Bernhard Baune; Thomas Tüting; Andreas Zimmer; Judith Alferink
Journal:  Int J Mol Sci       Date:  2020-01-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.